OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development of Novel Dihydrofuro[3,4-d]pyrimidine Derivatives as HIV-1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181C
Dongwei Kang, Yanying Sun, Da Feng, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2458-2470
Open Access | Times Cited: 13
Dongwei Kang, Yanying Sun, Da Feng, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2458-2470
Open Access | Times Cited: 13
Showing 13 citing articles:
Structure‐based design of diarylpyrimidines and triarylpyrimidines as potent HIV‐1 NNRTIs with improved metabolic stability and drug resistance profiles
Minghui Xie, Zhao Wang, Fabao Zhao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 5
Minghui Xie, Zhao Wang, Fabao Zhao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 5
Deciphering the enigmas of non‐nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistance
Kun Zhang, Yujie Zhang, Min Li, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 5
Kun Zhang, Yujie Zhang, Min Li, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 5
Design and Synthesis of Novel HIV-1 NNRTIs with Bicyclic Cores and with Improved Physicochemical Properties
Ladislav Prener, Ondřej Baszczyňski, Martin Kaiser, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1761-1777
Open Access | Times Cited: 12
Ladislav Prener, Ondřej Baszczyňski, Martin Kaiser, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1761-1777
Open Access | Times Cited: 12
Lead Optimization and Avoidance of Metabolic-perturbing Motif Developing Novel Diarylpyrimidines as Potent HIV-1 NNRTIs
Yanying Sun, Zhenzhen Zhou, Da Feng, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 23, pp. 15608-15626
Closed Access | Times Cited: 9
Yanying Sun, Zhenzhen Zhou, Da Feng, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 23, pp. 15608-15626
Closed Access | Times Cited: 9
Covalently Targeted Highly Conserved Tyr318 to Improve the Drug Resistance Profiles of HIV-1 NNRTIs: A Proof-of-Concept Study
Zhenzhen Zhou, Bairu Meng, Jiaqi An, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1215-1215
Open Access | Times Cited: 5
Zhenzhen Zhou, Bairu Meng, Jiaqi An, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1215-1215
Open Access | Times Cited: 5
Disubstituted pyrimidine-5-carboxamide derivatives as novel HIV-1 NNRTIs: Crystallographic overlay-based molecular design, synthesis, and biological evaluation
Da Feng, Hao Lin, Liyang Jiang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114957-114957
Closed Access | Times Cited: 8
Da Feng, Hao Lin, Liyang Jiang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114957-114957
Closed Access | Times Cited: 8
Identification of Novel Diarylpyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors against Wild-Type and K103N Mutant Viruses
Xiangyi Jiang, Waleed A. Zalloum, Zhen Gao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116941-116941
Closed Access | Times Cited: 1
Xiangyi Jiang, Waleed A. Zalloum, Zhen Gao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116941-116941
Closed Access | Times Cited: 1
Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors (2019-2023)
M. Nie, Shuang‐Shuang Zhang, Shuang‐Xi Gu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116973-116973
Closed Access | Times Cited: 1
M. Nie, Shuang‐Shuang Zhang, Shuang‐Xi Gu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116973-116973
Closed Access | Times Cited: 1
5-Cyano substituted diarylpyridines as potent HIV-1 NNRTIs: Rational design, synthesis, and activity evaluation
Hao Song, Yu Xia, Tao Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115686-115686
Closed Access | Times Cited: 2
Hao Song, Yu Xia, Tao Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115686-115686
Closed Access | Times Cited: 2
Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
Da Feng, Hao Lin, Liyang Jiang, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7538-7538
Open Access | Times Cited: 3
Da Feng, Hao Lin, Liyang Jiang, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7538-7538
Open Access | Times Cited: 3
Identification of Novel Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Exploring the Primer Grip Region
Tao Zhang, Zhongxia Zhou, Fabao Zhao, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1438-1438
Open Access | Times Cited: 1
Tao Zhang, Zhongxia Zhou, Fabao Zhao, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1438-1438
Open Access | Times Cited: 1
Design, synthesis and antitumor activity evaluation of pyrimidine derivatives containing 4-hydroxypiperidine group
Lingling Chi, Hao Wang, Fuqiang Yu, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 10, pp. 2125-2137
Closed Access
Lingling Chi, Hao Wang, Fuqiang Yu, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 10, pp. 2125-2137
Closed Access
Six-membered ring systems: diazines and benzo derivatives
K. Alison Rinderspacher
Progress in heterocyclic chemistry (2023), pp. 427-469
Closed Access
K. Alison Rinderspacher
Progress in heterocyclic chemistry (2023), pp. 427-469
Closed Access
